In vitro Evaluation of the Reno-Protective Effects of Captopril and Spironolactone in Streptozotocin-Induced Diabetic Nephropathy: Synergistic Antioxidant and Anti-Inflammatory Mechanisms
Journal of Young Pharmacists · 25.03.2026 · 18 (1) · 97-107
DOI: 10.5530/jyp.20260098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Young Pharmacists, online erschienen am 25.03.2026. Verfasst von Chandana Ganesha und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ganesha, C., Ali, M., & Raghunathanaidu, B. D. (2026). In vitro Evaluation of the Reno-Protective Effects of Captopril and Spironolactone in Streptozotocin-Induced Diabetic Nephropathy: Synergistic Antioxidant and Anti-Inflammatory Mechanisms. Journal of Young Pharmacists, 18(1), 97-107. https://doi.org/10.5530/jyp.20260098
Vancouver
Ganesha C, Ali M, Raghunathanaidu BD. In vitro Evaluation of the Reno-Protective Effects of Captopril and Spironolactone in Streptozotocin-Induced Diabetic Nephropathy: Synergistic Antioxidant and Anti-Inflammatory Mechanisms. Journal of Young Pharmacists. 2026;18(1):97-107. doi:10.5530/jyp.20260098
BibTeX
@article{Ganesha2026,
author = {Ganesha, Chandana and Ali, Mohammad and Raghunathanaidu, Bharathi Doddla},
title = {In vitro Evaluation of the Reno-Protective Effects of Captopril and Spironolactone in Streptozotocin-Induced Diabetic Nephropathy: Synergistic Antioxidant and Anti-Inflammatory Mechanisms},
journal = {Journal of Young Pharmacists},
year = {2026},
volume = {18},
number = {1},
pages = {97--107},
doi = {10.5530/jyp.20260098}
}
EUVIMED